OBJECTIVE: The Pediatric Asthma Diary was developed and validated to assess efficacy of interventions in children with asthma. DESIGN, PATIENTS, AND SETTING: Diary validation was performed in a three week, prospective study of 106 children aged 6-14 years with asthma. Children were classified at baseline as either stable (requiring no additional asthma treatment) or new onset/worse (requiring either addition of or increase in anti-inflammatory treatment). RESULTS: A daytime symptom scale and "day without asthma" were defined from diary questions. Both measures demonstrated significant validity and responsiveness to anti-inflammatory treatment. The stable group experienced a higher percentage of days without asthma during week 1 compared with the new onset/worse group (39.6% v 11.6%, respectively). The new onset/worse patients experienced significant improvement in days without asthma (24.5%) compared with stable patients (6.4%). CONCLUSIONS: The Pediatric Asthma Diary daytime symptom scale and day without asthma are acceptable measures for use in asthma intervention studies of children aged 6-14 years.
OBJECTIVE: The Pediatric Asthma Diary was developed and validated to assess efficacy of interventions in children with asthma. DESIGN, PATIENTS, AND SETTING: Diary validation was performed in a three week, prospective study of 106 children aged 6-14 years with asthma. Children were classified at baseline as either stable (requiring no additional asthma treatment) or new onset/worse (requiring either addition of or increase in anti-inflammatory treatment). RESULTS: A daytime symptom scale and "day without asthma" were defined from diary questions. Both measures demonstrated significant validity and responsiveness to anti-inflammatory treatment. The stable group experienced a higher percentage of days without asthma during week 1 compared with the new onset/worse group (39.6% v 11.6%, respectively). The new onset/worse patients experienced significant improvement in days without asthma (24.5%) compared with stable patients (6.4%). CONCLUSIONS: The Pediatric Asthma Diary daytime symptom scale and day without asthma are acceptable measures for use in asthma intervention studies of children aged 6-14 years.
Authors: G H Taylor; H H Rea; S McNaughton; L Smith; J Mulder; M I Asher; E A Mitchell; E Seelve; A W Stewart Journal: J Psychosom Res Date: 1991 Impact factor: 3.006
Authors: Sonali Bose; Gregory B Diette; Han Woo; Kirsten Koehler; Karina Romero; Ana M Rule; Barbara Detrick; Emily Brigham; Meredith C McCormack; Nadia N Hansel Journal: J Allergy Clin Immunol Pract Date: 2019-02-11
Authors: Jerry A Krishnan; Robert F Lemanske; Glorisa J Canino; Kurtis S Elward; Meyer Kattan; Elizabeth C Matsui; Herman Mitchell; E Rand Sutherland; Michael Minnicozzi Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: Tianshi David Wu; Emily P Brigham; Roger Peng; Kirsten Koehler; Cynthia Rand; Elizabeth C Matsui; Gregory B Diette; Nadia N Hansel; Meredith C McCormack Journal: J Allergy Clin Immunol Pract Date: 2018-05-03
Authors: Laura M Paulin; D 'Ann L Williams; Roger Peng; Gregory B Diette; Meredith C McCormack; Patrick Breysse; Nadia N Hansel Journal: Environ Res Date: 2017-08-07 Impact factor: 6.498
Authors: Lisa J Meltzer; Dean W Beebe; Stephanie Jump; Kassie Flewelling; D Sundström; Michael White; Pamela L Zeitlin; Matthew J Strand Journal: Sleep Med Date: 2019-07-23 Impact factor: 4.842